Clinical Trials Browser

Phase 2 × OTHER_GOV × Valganciclovir × Clear all

NCT03296553 2022-01-27

Impact of Valganciclovir on Severe IRIS-Kaposi Sarcoma Mortality: an Open-label, Parallel, Randomized Controlled-trial.

Phase 2 Completed

40 enrolled 6 charts

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, Immune Reconstitution Inflammatory Syndrome